|
|
| October 24, 2012: Dr. William F. Fearon and Dr. Duane Pinto discuss: FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating |
Dr. William F. Fearon and Dr. Duane Pinto discuss: FAME 2 Cost-effectiveness: A
Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in
Patients with Stable Coronary Artery Disease
St. Jude Medical:
-Grant/Research Support
NIH:
-Grant/Research Support
HeartFlow:
-Other Financial Benefit
FAME 2 was sponsored by St. Jude Medical
[ Download video ] |
|
No comments have been submitted
|